Posted On: 09/19/2014 11:12:04 AM
Post# of 30066
ICON offers central laboratory testing and biomarker services to the biopharmaceutical industry and has central laboratories and support staff in the United States, Ireland, Singapore, China and India. The Master Services Agreement covers all of ICON's laboratory sites worldwide.
"This agreement represents a major milestone for Amarantus, as we can now prepare LymPro for launch with a top-tier commercial development organization with the required CLIA capabilities as the backbone for launch in the United States and abroad," - GC
Why would we partner with only 1 big BP? If we partner with ICON and LymPro is able to what everyone is expecting, then it will back every other BP into a corner to have to use LymPro. Or it will push one BP to buy it and keep for themselves.
A BP will want to keep it out if the hands of any competition, no? No way, would they let other BP use it in order to help find a cure for ALZ before themselves.
"This agreement represents a major milestone for Amarantus, as we can now prepare LymPro for launch with a top-tier commercial development organization with the required CLIA capabilities as the backbone for launch in the United States and abroad," - GC
Why would we partner with only 1 big BP? If we partner with ICON and LymPro is able to what everyone is expecting, then it will back every other BP into a corner to have to use LymPro. Or it will push one BP to buy it and keep for themselves.
A BP will want to keep it out if the hands of any competition, no? No way, would they let other BP use it in order to help find a cure for ALZ before themselves.
(0)
(0)
